
The Precision Medicine World Conference (PMWC 2027) (January 27-29) brings back the PMWC Most Promising Company Competition—now the second Atul Butte Company Competition—to honor the memory of the late Dr. Butte, who championed evidence-first, data-driven translation, and inspired the PMWC community and beyond. This competition celebrates builders who turn data into care. Launched originally in 2009 to spotlight “rising star” startups in Diagnostics, Therapeutics, and Health Tech, the contest provides visibility and a platform to present before leading investors, potential clients, and partners, helping them accelerate their path forward. The winner of the Atul Butte Company Competition will be presented with a check for $20,000, donated by OpenEvidence. The competition will be held by presentations on the final day of the meeting (Friday, January 29). Request an application form by November 12.
Privately held precision medicine startups from Seed through Series A may apply. Areas include diagnostics, therapeutics, health tech, and AI and computational medicine. An in-person presenter is required. Competition format:
- Morning semi-finals: Each selected company gives a 5-minute presentation, followed by 2.5 minutes of judge Q&A.
- After lunch: The top three finalists are announced and advance to the afternoon main-stage finals.
- End of day: The winner is announced live and receives a $20,000 prize, sponsored by OpenEvidence.
The final-round judges are Alex Morgan of Khosla Ventures, Rowan Chapman of BEVC, and Travis Zack of OpenEvidence. Request an application form by November 12. There is no application fee, and selected companies will be published and promoted in December 2026. Selected presenters must purchase PMWC conference passes. Travel and lodging are not covered, and almost all spots are already committed. Learn more about the competition
